Back to Search
Start Over
APOLLON: A phase I/II study of panitumumab combined with TAS-102 in patients (pts) with RAS wild-type (wt) metastatic colorectal cancer (mCRC)
- Source :
- Journal of Clinical Oncology. 36:3523-3523
- Publication Year :
- 2018
- Publisher :
- American Society of Clinical Oncology (ASCO), 2018.
-
Abstract
- 3523Background: APOLLON is an open-label, single-arm phase I/II study investigating the efficacy and safety of panitumumab (Pmab) in combination with TAS-102 (trifluridine/tipiracil) in pts with RA...
- Subjects :
- Oncology
Cancer Research
medicine.medical_specialty
Colorectal cancer
business.industry
05 social sciences
Wild type
Trifluridine
medicine.disease
0506 political science
03 medical and health sciences
chemistry.chemical_compound
0302 clinical medicine
Phase i ii
chemistry
030220 oncology & carcinogenesis
Internal medicine
050602 political science & public administration
medicine
Panitumumab
In patient
business
Tipiracil
medicine.drug
Subjects
Details
- ISSN :
- 15277755 and 0732183X
- Volume :
- 36
- Database :
- OpenAIRE
- Journal :
- Journal of Clinical Oncology
- Accession number :
- edsair.doi...........4eb31d10bf8a487345d06701813e4068
- Full Text :
- https://doi.org/10.1200/jco.2018.36.15_suppl.3523